Motion Sickness Technology: The Emerging Tech Landscape

All articles

From galvanic vestibular stimulation to AI-driven motion prediction, the motion sickness technology landscape has shifted dramatically in the last decade. Here's what's established, what's emerging, and what's actually coming.

---

Motion sickness has been a problem since the first human sat on the first boat. For most of history, the "technology" for dealing with it consisted of ginger and willpower. In the last decade, that changed. Galvanic nerve stimulation wearables, smart glasses with dynamic visual cues, AI-driven motion sickness prediction, VR-based therapeutics, and connected intervention ecosystems have all emerged in rapid succession.

This guide maps the current and emerging motion sickness technology landscape — not as a shopping list, but as a view of where the field is heading. Most of the interesting work is happening at the experimental edge.

---

Section 1: Already-established consumer technology

This section is intentionally brief. For detailed product comparisons — wristbands versus medications, specific brand evaluations — see our full comparison guide. Here we focus on the landscape.

Acupressure wristbands (Sea-Band and variants)

Widely available, inexpensive ($8–$15), and mechanistically plausible — the P6 acupressure point stimulation has modest evidence for reducing nausea across several contexts including chemotherapy and pregnancy, with more limited evidence specific to motion sickness. Many users report benefit; randomized controlled trial evidence is mixed.

Electrical stimulation wristbands (ReliefBand)

FDA-cleared devices delivering transcutaneous electrical nerve stimulation at the P6 point. Stronger mechanism than passive acupressure, with controlled clinical studies showing nausea reduction. More expensive ($150–$200) and require charging. Effective for some users, not others.

Motion-synced glasses (Boarding Ring, Seetroen)

Liquid-filled frames that create an artificial horizon across the wearer's visual field, eliminating the conflict between the visual system (which sees a stationary interior) and the vestibular system (which detects vehicle motion). Mechanism is sound; clinical evidence is limited. User experiences are highly variable.

Cooling devices and fans

Personal fans and cooling patches reduce nausea through well-established physiological mechanisms: cool airflow on the face reduces vagal activation and lowers the nausea threshold. Simple, evidence-adjacent, and effective at the margins for many people.

---

Section 2: Emerging consumer technology

This is where the more interesting development is happening.

Galvanic vestibular stimulation (GVS) wearables

GVS devices deliver small electrical currents to electrodes placed on the mastoid bones behind the ears, directly modulating vestibular nerve activity. Research-grade GVS has shown significant promise: by matching the electrical stimulation pattern to the vehicle's motion profile, the device can provide the vestibular system with a signal that pre-adapts it to the incoming motion.

Consumer GVS devices are emerging at $200–$500 price points. The challenge is calibration — effective GVS requires precise electrode placement and current parameters matched to the individual's vestibular system. Research-grade equipment achieves this reliably; consumer devices are still working through the calibration problem.

This is one of the most mechanistically promising approaches in the category. Expect significant development here over the next 3–5 years.

Smart glasses with dynamic FOV reduction

Prototypes from research labs and early-stage companies dynamically reduce the peripheral visual field when motion sensors detect vehicle movement patterns associated with motion sickness. The mechanism: peripheral vision is the primary driver of visual-vestibular conflict in vehicles, so reducing peripheral visual input during high-conflict moments reduces the mismatch.

Not yet mass-market. Several teams at major technology companies are working on this as an integrated feature of consumer AR glasses rather than a standalone product.

AI-powered motion sickness prediction

Apps using smartphone accelerometers and GPS data to analyze travel patterns and predict when a passenger is likely to experience motion sickness — providing pre-emptive guidance ("put down your phone for the next 3 minutes") before symptoms develop. The logic is sound: motion sickness symptoms lag the triggering stimulus by minutes, so early intervention is substantially more effective than reactive response.

Early products in this category are not yet widely validated, but the approach is technically straightforward.

Biometric-adaptive systems

Wearables monitoring heart rate variability, galvanic skin response, and skin temperature continuously — early warning biomarkers for nausea onset that precede the conscious experience of symptoms by several minutes. Systems that detect these signals and trigger pre-emptive interventions (GVS stimulation, visual adjustments, rest alerts) before full symptoms develop.

This is still predominantly research-stage but moving toward consumer deployment.

Gamified vestibular training

VR-native games explicitly designed to deliver vestibular habituation training as entertainment. The player is progressively exposed to visual-vestibular conflict scenarios in a game context, building tolerance while engaged in gameplay. This addresses the primary adherence problem with vestibular training programs: it's boring. Games that make training engaging enough to complete consistently are a meaningful advance.

---

Section 3: In-vehicle and environmental technology

The vehicle and environmental side of motion sickness technology is developing independently of consumer wearables, and the investment scale is much larger.

Autonomous vehicle interior systems

The most significant near-term market for motion sickness technology is autonomous vehicles, where the problem manifests at consumer scale. Mercedes-Benz has developed dynamic ambient lighting that provides subtle visual cues about upcoming vehicle movements. BMW and Rolls-Royce have explored motion-synchronized display concepts. Waymo and other AV operators are developing AI driving profiles that minimize abrupt motions specifically to reduce passenger discomfort.

For deeper coverage of the AV motion sickness problem, see our complete guide to self-driving car motion sickness.

Smart vehicle cabin systems

Beyond lighting, emerging cabin systems include dynamic climate control (cooler air during high-motion segments), ionized air distribution, and biometric monitoring that detects passenger discomfort signals and adjusts vehicle parameters in response. The concept: the vehicle learns each passenger's motion sickness threshold and modulates its own behavior accordingly.

VR headset comfort systems

Major VR platforms have implemented several sickness-reduction technologies as standard: dynamic field-of-view reduction (vignetting) that automatically narrows the display during locomotion, teleportation locomotion that eliminates the most nauseating continuous movement options, and comfort modes that reduce visual motion altogether. These are now standard features, not premium additions.

Motion platforms for home simulators

Physical motion rigs for home simulation racing and flight ($500–$5,000+) that move the user's body to match the visual motion on screen, eliminating the visual-vestibular conflict entirely. Effective at reducing sim sickness; the cost limits the consumer market.

Aircraft turbulence prediction systems

AI systems helping commercial pilots anticipate and avoid turbulence through enhanced weather modeling and real-time atmospheric data aggregation. Indirectly reduces passenger motion sickness by reducing the frequency and severity of the primary airborne trigger.

---

Section 4: The research frontier

The most experimental work is happening in areas that won't produce consumer products for 5–10+ years.

Transcranial magnetic stimulation (TMS) for vestibular processing: Non-invasive brain stimulation targeting cortical areas involved in vestibular processing, with the goal of enhancing the brain's sensory integration capacity. Research-stage; consumer application is distant.

Closed-loop neurofeedback: Systems that continuously monitor vestibular processing signals and deliver compensating stimulation when early indicators of sensory conflict are detected — a real-time feedback loop between the body's state and an intervention system. The engineering challenge is significant.

Pharmacological neuroplasticity enhancement: Compounds that enhance the brain's plasticity during vestibular training, accelerating the adaptation process. Similar in principle to D-cycloserine research in PTSD treatment — the drug makes the learning more efficient rather than directly treating the condition. Early-stage animal and small human studies.

Genetic susceptibility profiling: Approximately 35 genetic variants have been identified with associations to motion sickness susceptibility. The research trajectory is toward precision medicine — genetic profiling informing which specific intervention (drug, training protocol, device) is most likely to be effective for a given individual.

Optogenetics research: Animal studies using light-activated proteins to precisely modulate specific vestibular circuit neurons, yielding mechanistic understanding that eventually informs more targeted interventions in humans. Far from clinical application but advancing the foundational science.

---

Section 5: The integration frontier

The most significant development in motion sickness technology over the next decade won't be a single breakthrough product — it will be the integration of multiple systems into ambient, continuous intervention.

Imagine: smart glasses with embedded motion sensors tracking your visual-vestibular state continuously. A wearable monitoring your biometric early-warning signals. Your AV communicating its motion profile to your glasses and wearable. An AI system coordinating all three — adjusting the visual environment, providing haptic cues, activating GVS when your signals indicate elevated conflict — all without you thinking about it.

This is the integration trajectory. Seamless intervention embedded into everyday devices rather than dedicated products you remember to use.

For the full picture of where motion sickness treatment is heading as a field, see our guide to the future of motion sickness treatment.

---

Section 6: The honest limitation of technology alone

Every technology reviewed in this article addresses either the trigger (vehicle design, visual adjustments) or the symptom in the moment (wristbands, GVS). None of them fundamentally changes your underlying susceptibility to sensory conflict.

The most durable solution targets the underlying susceptibility itself. The research on permanent susceptibility reduction establishes that brain training changes the processing capacity that determines how severely you respond to any sensory conflict — which is why it transfers across every trigger type, including all the emerging ones described in this article.

Technology complements training. It doesn't replace it. The person who has trained their vestibular system and also uses good GVS technology will have better outcomes than someone who only uses the technology. Start with the foundation.

---

The bottom line

Motion sickness technology is evolving rapidly. The experimental edge — GVS, biometric-adaptive systems, AI-driven prediction, integration ecosystems — points toward a future where intervention is continuous and embedded in everyday devices. But the foundational principle holds: the most effective response to motion sickness is a well-trained brain. Technology augments training. It doesn't substitute for it.

---

This article is part of the Future of Motion Sickness guide.

---

Sources

1. Golding JF, Gresty MA. "Pathophysiology and treatment of motion sickness." Current Opinion in Neurology. 2015;28(1):83–88.
2. Keshavarz B, et al. "Galvanic vestibular stimulation (GVS) as a tool to induce, modify, and suppress motion sickness: a systematic review." Frontiers in Neurology. 2020;11:601.
3. Smyth J, et al. "Visuospatial training reduces motion sickness susceptibility in healthy adults." Experimental Brain Research. 2021;239(4):1097–1113.
4. Diels C, Bos JE. "Self-driving carsickness." Applied Ergonomics. 2016;53(B):374–382.